• Astellas Pharma average return on tangible equity for 2023 was 29.48, a 15.29% increase from 2022.
• Astellas Pharma average return on tangible equity for 2022 was 34.8, a 9.59% decline from 2021.
• Astellas Pharma average return on tangible equity for 2021 was 38.49, a 4.06% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.